Masumoto N - Search Results

1

Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia.

Fujii T, Masumoto N, Saito M, Hirao N, Niimi S, Mukai M, Ono A, Hayashi S, Kubushiro K, Sakai E, Tsukazaki K, Nozawa S. Fujii T, et al. Among authors: masumoto n. Diagn Mol Pathol. 2005 Jun;14(2):103-8. doi: 10.1097/01.pas.0000162755.84026.9f. Diagn Mol Pathol. 2005. PMID: 15905694

2

Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas.

Ishikawa M, Fujii T, Masumoto N, Saito M, Mukai M, Nindl I, Ridder R, Fukuchi T, Kubushiro K, Tsukazaki K, Nozawa S. Ishikawa M, et al. Among authors: masumoto n. Int J Gynecol Pathol. 2003 Oct;22(4):378-85. doi: 10.1097/01.pgp.0000092135.88121.1f. Int J Gynecol Pathol. 2003. PMID: 14501820

3

P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix.

Masumoto N, Fujii T, Ishikawa M, Saito M, Iwata T, Fukuchi T, Susumu N, Mukai M, Kubushiro K, Tsukazaki K, Nozawa S. Masumoto N, et al. Hum Pathol. 2003 Aug;34(8):778-83. doi: 10.1016/s0046-8177(03)00284-3. Hum Pathol. 2003. PMID: 14506638

4

Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients.

Masumoto N, Fujii T, Ishikawa M, Mukai M, Ono A, Iwata T, Kubushiro K, Nozawa S. Masumoto N, et al. Gynecol Oncol. 2004 Aug;94(2):509-14. doi: 10.1016/j.ygyno.2004.05.011. Gynecol Oncol. 2004. PMID: 15297196

5

Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women.

Masumoto N, Fujii T, Ishikawa M, Mukai M, Saito M, Iwata T, Fukuchi T, Kubushiro K, Tsukazaki K, Nozawa S. Masumoto N, et al. Br J Cancer. 2003 Jun 16;88(12):1883-8. doi: 10.1038/sj.bjc.6601023. Br J Cancer. 2003. PMID: 12799631 Free PMC article.

6

Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.

Fujii T, Austin D, Guo D, Srimatkandada S, Wang T, Kubushiro K, Masumoto N, Tsukazaki K, Nozawa S, Deisseroth AB. Fujii T, et al. Among authors: masumoto n. Clin Cancer Res. 2003 Nov 1;9(14):5423-8. Clin Cancer Res. 2003. PMID: 14614029

7

Attenuation of pressure-induced myogenic contraction and tyrosine phosphorylation by fasudil, a cerebral vasodilator, in rat cerebral artery.

Masumoto N, Tanabe Y, Saito M, Nakayama K. Masumoto N, et al. Br J Pharmacol. 2000 May;130(2):219-30. doi: 10.1038/sj.bjp.0703292. Br J Pharmacol. 2000. PMID: 10807658 Free PMC article.

8

Specific attenuation of the pressure-induced contraction of rat cerebral artery by herbimycin A.

Masumoto N, Nakayama K, Oyabe A, Uchino M, Ishii K, Obara K, Tanabe Y. Masumoto N, et al. Eur J Pharmacol. 1997 Jul 2;330(1):55-63. doi: 10.1016/s0014-2999(97)00166-0. Eur J Pharmacol. 1997. PMID: 9228414

9

Amiloride-sensitive pressure-induced myogenic contraction in rat cerebral artery.

Oyabe A, Masumoto N, Ueta K, Nakayama K. Oyabe A, et al. Among authors: masumoto n. Fundam Clin Pharmacol. 2000 Jul-Aug;14(4):369-77. doi: 10.1111/j.1472-8206.2000.tb00418.x. Fundam Clin Pharmacol. 2000. PMID: 11030444

10

Interferon-alpha and -gamma inhibit the growth and neoplastic potential of v-src-transformed human epithelial cells by reducing Src tyrosine kinase activity.

Fujishima H, Nakano S, Tatsumoto T, Masumoto N, Niho Y. Fujishima H, et al. Among authors: masumoto n. Int J Cancer. 1998 May 4;76(3):423-9. doi: 10.1002/(sici)1097-0215(19980504)76:3<423::aid-ijc22>3.0.co;2-a. Int J Cancer. 1998. PMID: 9579582

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters